Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STLNW
3651
CALL
Starling Oncology Warrant
STLNW
$5.17M
| $276K | ﹤0.01% |
+27,450
| New | +$39.4K |
|
|
MARK
3652
DELISTED
Remark Holdings, Inc.
MARK
| $276K | ﹤0.01% |
+11,703
| New | +$180K |
|
3653
CALL
Insmed
INSM
$27.1B
| $275K | ﹤0.01% |
10,000
| – | – |
|
3654
United Natural Foods
UNFI
$2.94B
| $275K | ﹤0.01% |
15,113
-697,988
| -98% | -$10.5M |
|
3655
International Money Express
IMXI
$429M
| $274K | ﹤0.01% |
+21,955
| New | +$223K |
|
|
FLNT
3656
Fluent
FLNT
$132M
| $273K | ﹤0.01% |
25,536
-3,219
| -11% | -$36K |
|
3657
iBio
IBIO
$70.5M
| $273K | ﹤0.01% |
246
+72
| +41% | +$47.1K |
|
3658
Lifecore Biomedical
LFCR
$172M
| $273K | ﹤0.01% |
34,303
-60,417
| -64% | -$623K |
|
|
CLSD
3659
DELISTED
Clearside Biomedical
CLSD
| $272K | ﹤0.01% |
9,642
+4,896
| +103% | +$144K |
|
3660
Protara Therapeutics
TARA
$229M
| $271K | ﹤0.01% |
9,230
-33,189
| -78% | -$1.03M |
|
|
AXLA
3661
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $271K | ﹤0.01% |
+1,960
| New | +$240K |
|
3662
Harmonic Inc
HLIT
$1.31B
| $270K | ﹤0.01% |
56,778
-6,598
| -10% | -$36.9K |
|
3663
CALL
Southern Company
SO
$104B
| $270K | ﹤0.01% |
+5,200
| New | +$289K |
|
|
3664
PUT
Southern Company
SO
$104B
| $270K | ﹤0.01% |
+5,200
| New | +$289K |
|
|
SDC
3665
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $270K | ﹤0.01% |
34,179
-774,381
| -96% | -$5.25M |
|
3666
Grid Dynamics Holdings
GDYN
$638M
| $269K | ﹤0.01% |
38,961
-126,938
| -77% | -$1.04M |
|
|
PVLA
3667
Palvella Therapeutics
PVLA
$2.1B
| $269K | ﹤0.01% |
+1,086
| New | +$254K |
|
3668
Citizens Community Bancorp
CZWI
$201M
| $268K | ﹤0.01% |
38,997
-3,755
| -9% | -$26.3K |
|
3669
Duluth Holdings
DLTH
$143M
| $268K | ﹤0.01% |
36,424
-238,302
| -87% | -$1.22M |
|
3670
Erie Indemnity
ERIE
$14B
| $268K | ﹤0.01% |
1,394
-61,026
| -98% | -$10.7M |
|
3671
Pangaea Logistics
PANL
$547M
| $266K | ﹤0.01% |
105,954
+87,450
| +473% | +$190K |
|
|
PHX
3672
DELISTED
PHX Minerals
PHX
| $266K | ﹤0.01% |
99,342
+78,642
| +380% | +$294K |
|
|
ALYA
3673
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $266K | ﹤0.01% |
153,502
-1,188
| -0.8% | -$2.08K |
|
|
HNP
3674
DELISTED
Huaneng Power Intl, Inc.
HNP
| $266K | ﹤0.01% |
17,633
-3,558
| -17% | -$52.1K |
|
|
ODT
3675
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $265K | ﹤0.01% |
+6,260
| New | +$203K |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.